A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Medtronic is offering a peek into its ongoing ... study’s results would also help lay the groundwork for adaptive approaches ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

Medtronic expects this outperformance to continue ... machine Percept RC for use with patients experiencing neurological ...

The "Global Neurology Devices Market 2024 Edition: Market Size, Trends, Opportunities and Forecast by Product Type, Treatment Stage, End-Users, Region, By Country: 2020-2030" report has been added to ...

Medtronic plc (NYSE: MDT) is a leading global medical device maker in the medical sector. Its innovative and critical medical ...

Here are 10 of the best health care stocks to buy in 2024, according to CFRA analysts: *As of Sept. 10 close. Based on ...

Avicenna.ai SAS received U.S. FDA clearance for its Cina-Cspine algorithm, which uses machine learning technology to detect ...

Medtronic has been consistently growing at around single digits for several quarters. The company has launched around 130 products in the past year. More favorable market conditions could lead to ...

Following the recent recommendation of its advisory committee, the U.S. FDA gave the nod to Zevra Therapeutics Inc.’s ...

Medtronic faced challenges, including poor focus, lack of innovation, and COVID-19 impact, leading to share price stagnation since 2018. Despite recent improvements in performance, Medtronic ...